These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9524536)

  • 1. [Delayed vomiting after cytostatic chemotherapy].
    Münstedt K; Zygmunt M
    Dtsch Med Wochenschr; 1998 Feb; 123(9):255-8. PubMed ID: 9524536
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vomiting accompanying cytostatic treatment, and its control].
    Kotlarek-Haus S; Orzechowska-Juzwenko K; Gabryś K
    Pol Tyg Lek; 1984 Nov; 39(47):1555-9. PubMed ID: 6151174
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
    Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New aspects in the prevention and therapy of cytostatic drug-induced nausea and vomiting].
    Evers C; Riess H
    Z Arztl Fortbild (Jena); 1992 Sep; 86(17):847-53. PubMed ID: 1413901
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of chemotherapy-induced nausea and vomiting in patients with cancer.
    Aapro MS
    Ariz Med; 1981 Nov; 38(11):843-5. PubMed ID: 6274276
    [No Abstract]   [Full Text] [Related]  

  • 6. [The prevention of vomiting due to antineoplastic chemotherapy in the elderly cancer patient].
    Santini D; Vincenzi B; Finolezzi E; Di Cosimo S; Gravante G; Spoto S; Tonini G
    Minerva Med; 1999; 90(7-8):205-9. PubMed ID: 10719419
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapy of malignant tumors, vomiting and nausea--what to do?].
    Ell C; König HJ
    Fortschr Med; 1984 Oct; 102(37):913-5. PubMed ID: 6500448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy. An overview of nausea and vomiting in the cancer patient: etiology and management of serious complications of chemotherapy.
    Needleman R
    AAOHN J; 1987 Apr; 35(4):179-82. PubMed ID: 2950890
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance and principles of antiemetic therapy in cytostatic treatment].
    Joss R; Buser K; Cerny T; Rohrbach D; Brunner KW
    Ther Umsch; 1988 Jun; 45(6):397-402. PubMed ID: 3046037
    [No Abstract]   [Full Text] [Related]  

  • 10. Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice.
    Antonarakis ES; Hain RD
    Arch Dis Child; 2004 Sep; 89(9):877-80. PubMed ID: 15321871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiemetics in cytostatic-induced vomiting].
    Jungmayr P
    Med Monatsschr Pharm; 2010 Feb; 33(2):49-54; quiz 55-6. PubMed ID: 20184263
    [No Abstract]   [Full Text] [Related]  

  • 12. New directions in managing chemotherapy-related emesis.
    Krasnow SH
    Oncology (Williston Park); 1991 Sep; 5(9 Suppl):19-24. PubMed ID: 1836346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy induced-vomiting--a practical guide for prevention and therapy].
    Jordan K; Voigt W; Schmoll HJ
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1869-72. PubMed ID: 16915549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of vomiting due to chemotherapy.
    Zulkhairi ; Kar AS
    Acta Med Indones; 2004; 36(4):219-26. PubMed ID: 15931721
    [No Abstract]   [Full Text] [Related]  

  • 15. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.
    Bloechl-Daum B; Deuson RR; Mavros P; Hansen M; Herrstedt J
    J Clin Oncol; 2006 Sep; 24(27):4472-8. PubMed ID: 16983116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention and therapy of cytostatic-induced vomiting].
    Riess H; Ludat K
    Dtsch Med Wochenschr; 1991 May; 116(18):705-12. PubMed ID: 2026101
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics.
    Grunberg SM; Deuson RR; Mavros P; Geling O; Hansen M; Cruciani G; Daniele B; De Pouvourville G; Rubenstein EB; Daugaard G
    Cancer; 2004 May; 100(10):2261-8. PubMed ID: 15139073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience. The Nordic Antiemetic Trial Group.
    Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Andersson H; Hansen O; Sørensen BT; Räisänen I
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():31-6. PubMed ID: 7749168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of success: parameters of efficacy.
    de Mulder PH
    Br J Cancer Suppl; 1992 Dec; 19():S68. PubMed ID: 1467205
    [No Abstract]   [Full Text] [Related]  

  • 20. [Management of emesis in cancer patients].
    Slimane K; Perez A; Ruffié P; di Palma M
    Bull Cancer; 2004 May; 91(5):403-8. PubMed ID: 15281279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.